Tesli, M., Koefoed, P., Athanasiu, L., Mattingsdal, M., Gustafsson, O., Agartz, I., Rimol, L. M., Brown, A., Wirgenes, K. V., Smorr, L.-L., Kähler, A. K., Werge, T.
, Mors, O., Mellerup, E., Jönsson, E. G., Melle, I., Morken, G., Djurovic, S. & Andreassen, O. A. (2011).
Association analysis of ANK3 gene variants in nordic bipolar disorder and schizophrenia case-control samples.
American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics,
156(8), 969-74.
https://doi.org/10.1002/ajmg.b.31244
Serafini, M., Jakszyn, P., Luján-Barroso, L., Agudo, A., Bueno-de-Mesquita, H. B., van Duijnhoven, F. J. B., Jenab, M., Navarro, C., Palli, D., Boeing, H., Wallström, P., Regnér, S., Numans, M. E., Carneiro, F., Boutron-Ruault, M.-C., Clavel-Chapelon, F., Morois, S., Grioni, S., Panico, S. ... González, C. A. (2012).
Dietary total antioxidant capacity and gastric cancer risk in the european prospective investigation into cancer and nutrition study.
International Journal of Cancer,
131(4), E544-54.
https://doi.org/10.1002/ijc.27347
Pedersen, C. B., Demontis, D., Pedersen, M. S., Agerbo, E., Mortensen, P. B., Børglum, A., Hougaard, D. M., Hollegaard, M. V.
, Mors, O. & Cantor-Graae, E. (2012).
Risk of schizophrenia in relation to parental origin and genome-wide divergence.
Psychological Medicine,
42(7), 1515-1521.
https://doi.org/10.1017/S0033291711002376
Kesmodel, U. S., Mørup, L., Hviid, U. R., Sander, P.
, Bek, K. M., Hansen, U. D. & Lose, G. (2011).
Private klinikker forsømmer at indberette.
Ugeskrift for Læger,
173(46), 2971.
Jensen, V.
, Sørensen, F. B., Bentzen, S. M.
, Ladekarl, M., Nielsen, O. S., Keller, J. & Jensen, O. M. (1998).
Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Histopathology,
32(6), 536-46.
https://doi.org/10.1046/j.1365-2559.1998.00425.x
Schöffski, P., Ray-Coquard, I. L., Cioffi, A., Bui, N. B., Bauer, S., Hartmann, J. T., Krarup-Hansen, A., Grünwald, V., Sciot, R., Dumez, H., Blay, J.-Y., Le Cesne, A., Wanders, J., Hayward, C., Marreaud, S., Ouali, M., Hohenberger, P., European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG)
& Nielsen, O. S. (2011).
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.
Lancet Oncology,
12(11), 1045-1052.
https://doi.org/10.1016/S1470-2045(11)70230-3